Form 13G TrueBlue For: 16 January
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
TrueBlue Inc (TBI)
TrueBlue Inc stock price live, this page displays NYSE TBI stock exchange data. View the TBI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the TrueBlue Inc real time stock price chart below.
What Is the TrueBlue Inc Stock Price Today?
The TrueBlue Inc stock price today is 5.30.
What Is the Stock Symbol for TrueBlue Inc?
The stock symbol for TrueBlue Inc is "TBI."
What Stock Exchange Does TrueBlue Inc Trade On?
TrueBlue Inc is listed and trades on the NYSE stock exchange.
Is TrueBlue Inc a Good Stock to Buy?
Determining whether TrueBlue Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TBI quote. (ISIN: US89785X1019)
What Is the TrueBlue Inc Stock Price Today?
The TrueBlue Inc stock price today is 5.30.
What Is the Stock Symbol for TrueBlue Inc?
The stock symbol for TrueBlue Inc is "TBI."
What Stock Exchange Does TrueBlue Inc Trade On?
TrueBlue Inc is listed and trades on the NYSE stock exchange.
Is TrueBlue Inc a Good Stock to Buy?
Determining whether TrueBlue Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TBI quote. (ISIN: US89785X1019)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.26
5.58
52 wk Range
3.45
8.55
Earnings results expected in 11 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.265.58
52 wk Range
3.458.55
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
TBI Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
8.50
Upside
+60.38%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low Price / Book multiple
- Form 8K TrueBlue Inc For: 9 January
- Investing.com
- Form 13G TrueBlue For: 16 January
- Investing.com
- Form 8K TrueBlue Inc For: 9 January
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral
TrueBlue Inc Company Profile
TrueBlue, Inc., together with its subsidiaries, provides specialized workforce solutions in the United States, Canada, the United Kingdom, Australia, and Puerto Rico. It operates through three segments: PeopleReady, PeopleManagement, and PeopleScout. The PeopleReady segment provides general, industrial, and skilled trade contingent staffing services for construction, transportation, manufacturing, retail, hospitality, and energy industries. The PeopleManagement segment offers contingent, on-site industrial staffing, and commercial driver services, which includes on-site management and recruitment for the contingent industrial workforce of manufacturing, warehousing, and distribution facilities; and recruitment and management of contingent and dedicated commercial drivers to the transportation and distribution industries under the Staff Management, SIMOS Insourcing Solutions, and Centerline Drivers brands. The PeopleScout segment provides recruitment process outsourcing, talent advisory services, and managed service provider solutions including sourcing, screening, hiring, and onboarding services; operates Affinix, a technology platform for sourcing, screening, and delivering a permanent workforce to its clients; talent advisory solutions, such as employer branding, recruitment marketing, talent insights, candidate assessment, and talent acquisition strategy consulting services; and contingent labor programs, including vendor selection, performance management, compliance monitoring, and risk management. The company was formerly known as Labor Ready, Inc. and changed its name to TrueBlue, Inc. in December 2007. The company was incorporated in 1985 and is headquartered in Tacoma, Washington.
TrueBlue Inc SWOT Analysis
Staffing Sector Outlook | TrueBlue navigates economic headwinds in the staffing industry, poised for potential recovery as a bellwether for broader market trends |
Financial Challenges | Revenue decline and negative EPS projections reflect industry-wide struggles, with analysts setting price targets between $10 and $13 |
Strategic Positioning | Explore TrueBlue's focus on digital transformation, market expansion, and cost management to capitalize on emerging secular growth drivers |
Recovery Potential | Learn how TrueBlue's strong position in light industrial staffing could lead to significant upside during economic rebound, with target margins of 17-22% |
TrueBlue Inc Earnings Call Summary for Q3/2025
- TrueBlue exceeded Q3 2025 expectations with EPS of $0.03 (vs $0.02 forecast) and revenue of $431M (up 13% YoY), despite stock declining 1.27% in after-hours trading
- PeopleSolutions segment drove growth with a 28% revenue increase, while the company reduced SG&A expenses by 8%, improving operational efficiency despite gross margin decline
- Despite posting a $2M net loss, TrueBlue reported $1M in adjusted net income and $11M in adjusted EBITDA, maintaining a cash position of $20M against $68M in debt
- CEO Taryn Owen highlighted the company's 'digitally-enabled specialized workforce solutions' as key differentiators in addressing complex talent challenges
- Management forecasts Q4 revenue growth of 4-10% YoY, with Healthcare Staffing Professionals expected to be a significant contributor to future growth
Last Updated: 2025-11-03, 06:06 p/m
Read Full TranscriptCompare TBI to Peers and Sector
Metrics to compare | TBI | Sector Sector - Average of metrics from a broad group of related Industrials sector companies | Relationship RelationshipTBIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.6x | 13.4x | 12.5x | |
PEG Ratio | −0.08 | 0.61 | 0.03 | |
Price/Book | 0.5x | 1.8x | 1.4x | |
Price / LTM Sales | 0.1x | 1.3x | 1.3x | |
Upside (Analyst Target) | 53.4% | 32.6% | 14.5% | |
Fair Value Upside | Unlock | 20.0% | 5.3% | Unlock |
Analyst Ratings
1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 8.50
(+60.38% Upside)
Earnings
Latest Release
Nov 03, 2025
EPS / Forecast
0.03 / 0.02
Revenue / Forecast
431.00M / 393.19M
People Also Watch
FAQ
What Is the TrueBlue (TBI) Stock Price Today?
The TrueBlue stock price today is 5.30
What Stock Exchange Does TrueBlue Trade On?
TrueBlue is listed and trades on the New York Stock Exchange stock exchange.
What Is the Stock Symbol for TrueBlue?
The stock symbol for TrueBlue is "TBI."
What Is the TrueBlue Market Cap?
As of today, TrueBlue market cap is 158.68M.
What Is TrueBlue's Earnings Per Share (TTM)?
The TrueBlue EPS (TTM) is -0.95.
When Is the Next TrueBlue Earnings Date?
TrueBlue will release its next earnings report on Feb 04, 2026.
From a Technical Analysis Perspective, Is TBI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has TrueBlue Stock Split?
TrueBlue has split 5 times.
How Many Employees Does TrueBlue Have?
TrueBlue has 4200 employees.
What is the current trading status of TrueBlue (TBI)?
As of Jan 24, 2026, TrueBlue (TBI) is trading at a price of 5.30, with a previous close of 5.54. The stock has fluctuated within a day range of 5.26 to 5.58, while its 52-week range spans from 3.45 to 8.55.
What Is TrueBlue (TBI) Price Target According to Analysts?
The average 12-month price target for TrueBlue is USD8.50, with a high estimate of USD10 and a low estimate of USD7. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +60.38% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.